Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00403052
Status:
TERMINATED
Last Update Posted:
2019-04-16
First Post:
2006-11-21
Brief Title:
A Study of 1018 Immunostimulatory Sequence ISS Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer
Sponsor:
Dynavax Technologies Corporation
Organization:
Dynavax Technologies Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-21
First Submit QC Date:
November 21 2006
Study First Post Date:
2006-11-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-11
Last Update Post Date:
2019-04-16
Last Update Post Date Type:
ACTUAL